Godlike Productions - Reply to Thread

Users Online Now: 2,228 (Who's On?)	Visitors Today: 957,461
Pageviews Today: 1,597,020	Threads Today: 645	Posts Today: 11,494
04:00 PM

Back to Thread

REPLY TO THREAD

Subject CDC data is now reporting that people who received the Janssen (Ad.26.COV2.S) Vaccine is more likely to experience GBS (Guillain-Barre Syndrome)

User Name

Font color: Font:

In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article.

Original Message CDC study shows risk of Guillain-Barré syndrome elevated after Ad.26.COV2.S COVID vaccination

To date, three vaccines have been granted emergency used authorization (EUA) in the United States (US) to prevent coronavirus disease 2019 (COVID-19). These vaccines include BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna), both of which are mRNA-based vaccines, as well as Ad.26.COV2.S (Janssen).

BNT162b2 and mRNA-1273 are both administered primarily as double-doses, with a third booster shot that has recently been approved after six months. The Ad.26.COV2.S is a replication-incompetent adenoviral vector vaccine and is primarily administered as a single dose; however, the U.S. Food and Drug Administration (FDA) has recently advised Ad.26.COV2.S recipients to receive a booster dose of any approved COVID-19 vaccine after two months.

...

Guillain-Barré syndrome (GBS) is a rare neurological disorder with an incidence rate of 1-2 per 100,000 person-years. In July 2021, data from the Vaccine Adverse Event Reporting System (VAERS) indicated that more cases of GBS were being reported after vaccination with Ad.26.COV2.S in comparison to other mRNA vaccines.

...

This interim analysis of surveillance data of COVID-19 vaccines demonstrates that there is an elevated risk of GBS observed after primary Ad.26.COV2.S vaccination. Surveillance is ongoing and more results are awaited.

----- SNIP -----

Source: [link to www.news-medical.net (secure)]

Is this the beginning of the avalanche? Or has it already taken place and it's just not being reported as such, as seen with other disorders such as increases in hypertension and blood-clots?

Pictures (click to insert)